Paint Therapeutics
Paint Therapeutics is reimagining drug delivery through the lungs. Our proprietary Peptide Drug Conjugate Platforms enable targeted pulmonary delivery with precise control over drug release and systemic exposure. We improve efficacy, reduce toxicity, and unlock new IP for therapies limited by oral administration, first-pass metabolism, or short half-lives. With PulmoPaint™ and SystemoPaint™, we have developed targeted delivery technologies that address longstanding limitations in efficacy, safety, and bioavailability.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Paint Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
Showing 1 of 2 verified contacts
Top roles at Paint Therapeutics
2 distinct titles indexed · top 2 shown.
- 1chief executive officer
- 1scientific consultant
Sign up to unlock all 2 contacts at Paint Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Paint Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.